大塚ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/01/26 | 5,794 | 5,817 | 5,752 | 5,785 | +28 | +0.5% | 813,300 |
| 2024/01/25 | 5,773 | 5,825 | 5,747 | 5,757 | -46 | -0.8% | 601,300 |
| 2024/01/24 | 5,839 | 5,873 | 5,786 | 5,803 | -108 | -1.8% | 738,100 |
| 2024/01/23 | 5,876 | 5,974 | 5,871 | 5,911 | +50 | +0.9% | 720,500 |
| 2024/01/22 | 5,836 | 5,874 | 5,816 | 5,861 | +71 | +1.2% | 504,400 |
| 2024/01/19 | 5,828 | 5,847 | 5,738 | 5,790 | -34 | -0.6% | 933,500 |
| 2024/01/18 | 5,836 | 5,872 | 5,787 | 5,824 | +16 | +0.3% | 923,300 |
| 2024/01/17 | 5,816 | 5,892 | 5,787 | 5,808 | +17 | +0.3% | 893,100 |
| 2024/01/16 | 5,864 | 5,871 | 5,774 | 5,791 | -114 | -1.9% | 770,400 |
| 2024/01/15 | 5,803 | 5,915 | 5,790 | 5,905 | +71 | +1.2% | 624,400 |
| 2024/01/12 | 5,960 | 5,977 | 5,819 | 5,834 | -34 | -0.6% | 1,389,900 |
| 2024/01/11 | 5,875 | 5,883 | 5,826 | 5,868 | +93 | +1.6% | 1,278,100 |
| 2024/01/10 | 5,707 | 5,812 | 5,679 | 5,775 | +135 | +2.4% | 1,409,200 |
| 2024/01/09 | 5,634 | 5,677 | 5,603 | 5,640 | +53 | +0.9% | 1,205,800 |
| 2024/01/05 | 5,546 | 5,612 | 5,546 | 5,587 | +96 | +1.7% | 1,164,800 |
| 2024/01/04 | 5,373 | 5,491 | 5,309 | 5,491 | +202 | +3.8% | 1,075,600 |
| 2023/12/29 | 5,284 | 5,332 | 5,244 | 5,289 | -5 | -0.1% | 1,032,600 |
| 2023/12/28 | 5,374 | 5,401 | 5,291 | 5,294 | -142 | -2.6% | 837,500 |
| 2023/12/27 | 5,418 | 5,460 | 5,390 | 5,436 | +21 | +0.4% | 1,390,800 |
| 2023/12/26 | 5,441 | 5,457 | 5,390 | 5,415 | -12 | -0.2% | 778,500 |
| 2023/12/25 | 5,417 | 5,464 | 5,415 | 5,427 | +110 | +2.1% | 846,800 |
| 2023/12/22 | 5,255 | 5,332 | 5,255 | 5,317 | +63 | +1.2% | 846,200 |
| 2023/12/21 | 5,260 | 5,290 | 5,212 | 5,254 | -19 | -0.4% | 1,185,500 |
| 2023/12/20 | 5,236 | 5,310 | 5,216 | 5,273 | +67 | +1.3% | 979,200 |
| 2023/12/19 | 5,193 | 5,236 | 5,170 | 5,206 | +22 | +0.4% | 847,100 |
| 2023/12/18 | 5,184 | 5,200 | 5,118 | 5,184 | -46 | -0.9% | 1,205,100 |
| 2023/12/15 | 5,383 | 5,385 | 5,217 | 5,230 | -190 | -3.5% | 1,997,200 |
| 2023/12/14 | 5,540 | 5,571 | 5,396 | 5,420 | -141 | -2.5% | 1,290,600 |
| 2023/12/13 | 5,652 | 5,660 | 5,560 | 5,561 | -140 | -2.5% | 942,300 |
| 2023/12/12 | 5,778 | 5,838 | 5,685 | 5,701 | +6 | +0.1% | 1,109,300 |
| 2023/12/11 | 5,653 | 5,707 | 5,617 | 5,695 | +112 | +2% | 907,600 |
| 2023/12/08 | 5,691 | 5,691 | 5,559 | 5,583 | -146 | -2.5% | 1,573,500 |
| 2023/12/07 | 5,760 | 5,779 | 5,711 | 5,729 | -28 | -0.5% | 877,100 |
| 2023/12/06 | 5,704 | 5,760 | 5,682 | 5,757 | +72 | +1.3% | 744,400 |
| 2023/12/05 | 5,704 | 5,732 | 5,676 | 5,685 | +7 | +0.1% | 886,200 |
| 2023/12/04 | 5,675 | 5,693 | 5,618 | 5,678 | -46 | -0.8% | 690,200 |
| 2023/12/01 | 5,733 | 5,745 | 5,692 | 5,724 | +35 | +0.6% | 928,000 |
| 2023/11/30 | 5,624 | 5,735 | 5,606 | 5,689 | +68 | +1.2% | 4,310,300 |
| 2023/11/29 | 5,575 | 5,637 | 5,540 | 5,621 | -14 | -0.2% | 966,100 |
| 2023/11/28 | 5,605 | 5,638 | 5,573 | 5,635 | +3 | +0.1% | 801,300 |
| 2023/11/27 | 5,710 | 5,714 | 5,613 | 5,632 | -38 | -0.7% | 798,600 |
| 2023/11/24 | 5,650 | 5,710 | 5,635 | 5,670 | +91 | +1.6% | 780,200 |
| 2023/11/22 | 5,504 | 5,650 | 5,496 | 5,579 | +86 | +1.6% | 989,500 |
| 2023/11/21 | 5,450 | 5,509 | 5,409 | 5,493 | +18 | +0.3% | 909,300 |
| 2023/11/20 | 5,527 | 5,560 | 5,465 | 5,475 | -71 | -1.3% | 859,400 |
| 2023/11/17 | 5,500 | 5,554 | 5,457 | 5,546 | +68 | +1.2% | 906,100 |
| 2023/11/16 | 5,547 | 5,589 | 5,445 | 5,478 | -75 | -1.4% | 1,312,000 |
| 2023/11/15 | 5,560 | 5,617 | 5,502 | 5,553 | +30 | +0.5% | 1,463,900 |
| 2023/11/14 | 5,550 | 5,560 | 5,477 | 5,523 | -5 | -0.1% | 1,070,600 |
| 2023/11/13 | 5,497 | 5,583 | 5,439 | 5,528 | +97 | +1.8% | 1,067,000 |
301～
350
件表示中 / 3509件
類似銘柄と比較する
現在ご覧いただいている「大塚ＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大塚ＨＤ | 683,000円 | +2.2% | +10.2% | 1.76% | 13.11倍 | 1.32倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| 武 田 | 428,800円 | +7.7% | +206.9% | 4.57% | 57.35倍 | 0.98倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 第一三共 | 321,400円 | +14.3% | +26.5% | 1.87% | 25.16倍 | 3.69倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| アステラス薬 | 135,200円 | +18.5% | -96.0% | 5.47% | 172.89倍 | 1.58倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 240,800円 | +5.7% | +3.9% | 2.38% | 11.98倍 | 1.58倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム
